Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Disc Medicine, Inc. - Common Stock (NQ: IRON ) 50.82 +2.02 (+4.14%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Disc Medicine, Inc. - Common Stock < Previous 1 2 Next > Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares June 22, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants June 13, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants June 12, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress June 09, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Participate in the Jefferies Healthcare Conference May 31, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update May 15, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress May 11, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference April 21, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP) April 13, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update March 31, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA) March 21, 2023 IND accepted for phase 2 clinical trial in DBA patients; study is expected to initiate mid-year 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Opco Inc (NASDAQ: IRON) Investor Notice: Investigation over Possible Securities Laws Violations March 20, 2023 San Diego, CA -- (SBWIRE) -- 03/20/2023 -- An investigation was announced for investors of Disc Medicine Opco Inc (NASDAQ: IRON) shares over potential securities laws violations in connection with... Via SBWire Disc Medicine Initiates a Phase 1b/2 Clinical Study of DISC-0974 in Adults with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) and Anemia February 16, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces $62.5 Million Financing led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs February 14, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine to Participate in SVB Securities Global Biopharma Conference February 08, 2023 From Disc Medicine Inc Via GlobeNewswire Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis January 20, 2023 From Disc Medicine Inc Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.